Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.
• assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP480329.RASxRDwQgnY4-F1_12-5ctSsIDhQJLDUFIUhOMD0HLOyg130_assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480329.RASxRDwQgnY4-F1_12-5ctSsIDhQJLDUFIUhOMD0HLOyg130_provenance.
• NP480332.RAYHhJ3aieTFwkmyonK5RFucelKFHzZdAjJVrrbhSXi-8130_assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480332.RAYHhJ3aieTFwkmyonK5RFucelKFHzZdAjJVrrbhSXi-8130_provenance.
• NP480333.RAQpyC_CqFL7fslF2eTqjmwP-AW489L1MuHN_wc_ZwBzc130_assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480333.RAQpyC_CqFL7fslF2eTqjmwP-AW489L1MuHN_wc_ZwBzc130_provenance.
• NP480330.RAp1D9qVEr940WL4Ea0d6zLreNpl1707gAgbhT-TDn7As130_assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480330.RAp1D9qVEr940WL4Ea0d6zLreNpl1707gAgbhT-TDn7As130_provenance.
• NP573944.RA6IW-0Cc7n_-wcGfbUAvzo1GhwmNSFY0yQ7EZVs0PFDs130_assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573944.RA6IW-0Cc7n_-wcGfbUAvzo1GhwmNSFY0yQ7EZVs0PFDs130_provenance.
• NP480327.RAzW3BbaI4jH4SnMv9uoQHlJ7Nu7lInog9CTlBndSd6Js130_assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480327.RAzW3BbaI4jH4SnMv9uoQHlJ7Nu7lInog9CTlBndSd6Js130_provenance.
• NP480336.RA7rRpj0Tz0Fr2S0VURWj1JOb3tnP1Aq4qNT_I0A5VyY0130_assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480336.RA7rRpj0Tz0Fr2S0VURWj1JOb3tnP1Aq4qNT_I0A5VyY0130_provenance.